SAN FRANCISCO — Two years after he sold the biotechnology company Genzyme Corp. to a French pharmaceutical giant, Henri A. Termeer isn’t exactly settling into the comforts of retirement at his seaside homes north of Boston and in Maine.
Henri Termeer isn’t exactly settling into retirement
Not content to rest on his laurels, the former Genzyme chief stays busy as a tireless advocate for the Massachusetts biotech industry
You have reached the limit of 10 free articles in a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than 25¢ a week